Mice with Pulmonary Fibrosis Driven by Telomere Dysfunction

Cell Reports

Volumn 12, Issue 2, 2015, Pages 286-299

  Povedano, Juan M ^a   Martinez, Paula ^a   Flores, Juana M ^b   Mulero, Francisca ^a   Blasco, Maria A ^a  

^a Centro Nacional de Investigations Oncológicas   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; INTERLEUKIN 6; PROTEIN P19; PROTEIN P21; PROTEIN P53; TELOMERASE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; TAMOXIFEN; TELOMERIC REPEAT BINDING FACTOR 1;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL AGING; CELL COUNT; CELL DAMAGE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; FIBROSING ALVEOLITIS; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; MACROPHAGE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERE; TELOMERE SHORTENING; ANIMAL; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; DNA REPAIR; DRUG EFFECTS; FEMALE; GENETICS; KNOCKOUT MOUSE; LUNG; METABOLISM; PATHOLOGY; RADIOGRAPHY;

MUS;

ANIMALS; BLEOMYCIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DISEASE MODELS, ANIMAL; DNA DAMAGE; DNA REPAIR; FEMALE; IDIOPATHIC PULMONARY FIBROSIS; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TAMOXIFEN; TELOMERASE; TELOMERE; TELOMERE SHORTENING; TELOMERIC REPEAT BINDING PROTEIN 1; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84937525785     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.06.028     Document Type: Article

References (48)

1. Alder J.K., Chen J.J., Lancaster L., Danoff S., Su S.C., Cogan J.D., Vulto I., Xie M., Qi X., Tuder R.M., et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 2008, 105:13051-13056.
2. Alder J.K., Guo N., Kembou F., Parry E.M., Anderson C.J., Gorgy A.I., Walsh M.F., Sussan T., Biswal S., Mitzner W., et al. Telomere length is a determinant of emphysema susceptibility. Am. J. Respir. Crit. Care Med. 2011, 184:904-912.
3. Alder J.K., Barkauskas C.E., Limjunyawong N., Stanley S.E., Kembou F., Tuder R.M., Hogan B.L., Mitzner W., Armanios M. Telomere dysfunction causes alveolar stem cell failure. Proc. Natl. Acad. Sci. USA 2015, 112:5099-5104.
4. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J. Clin. Invest. 2013, 123:996-1002.
5. Armanios M., Blackburn E.H. The telomere syndromes. Nat. Rev. Genet. 2012, 13:693-704.
6. Armanios M.Y., Chen J.J., Cogan J.D., Alder J.K., Ingersoll R.G., Markin C., Lawson W.E., Xie M., Vulto I., Phillips J.A., et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 2007, 356:1317-1326.
7. Beier F., Foronda M., Martinez P., Blasco M.A. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita. Blood 2012, 120:2990-3000.
8. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106:661-673.
9. Blasco M.A. Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet. 2005, 6:611-622.
10. Blasco M.A. Telomere length, stem cells and aging. Nat. Chem. Biol. 2007, 3:640-649.
11. Blasco M.A., Lee H.W., Hande M.P., Samper E., Lansdorp P.M., DePinho R.A., Greider C.W. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997, 91:25-34.
12. Broytman O., Braun R.K., Morgan B.J., Pegelow D.F., Hsu P.N., Mei L.S., Koya A.K., Eldridge M., Teodorescu M. Effects of chronic intermittent hypoxia on allergen-induced airway inflammation in rats. Am. J. Respir. Cell Mol. Biol. 2015, 52:162-170.
13. Canela A., Vera E., Klatt P., Blasco M.A. High-throughput telomere length quantification by FISH and its application to human population studies. Proc. Natl. Acad. Sci. USA 2007, 104:5300-5305.
14. Chong L., van Steensel B., Broccoli D., Erdjument-Bromage H., Hanish J., Tempst P., de Lange T. A human telomeric protein. Science 1995, 270:1663-1667.
15. Collado M., Blasco M.A., Serrano M. Cellular senescence in cancer and aging. Cell 2007, 130:223-233.
16. de Lange T. Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev. 2005, 19:2100-2110.
17. Degryse A.L., Xu X.C., Newman J.L., Mitchell D.B., Tanjore H., Polosukhin V.V., Jones B.R., McMahon F.B., Gleaves L.A., Phillips J.A., et al. Telomerase deficiency does not alter bleomycin-induced fibrosis in mice. Exp. Lung Res. 2012, 38:124-134.
18. Desai T.J., Brownfield D.G., Krasnow M.A. Alveolar progenitor and stem cells in lung development, renewal and cancer. Nature 2014, 507:190-194.
19. Diéguez-Hurtado R., Martín J., Martínez-Corral I., Martínez M.D., Megías D., Olmeda D., Ortega S. A Cre-reporter transgenic mouse expressing the far-red fluorescent protein Katushka. Genesis 2011, 49:36-45.
20. Dobbs L.G. Isolation and culture of alveolar type II cells. Am. J. Physiol. 1990, 258:L134-L147.
21. Ferrón S., Mira H., Franco S., Cano-Jaimez M., Bellmunt E., Ramírez C., Fariñas I., Blasco M.A. Telomere shortening and chromosomal instability abrogates proliferation of adult but not embryonic neural stem cells. Development 2004, 131:4059-4070.
22. Flores I., Cayuela M.L., Blasco M.A. Effects of telomerase and telomere length on epidermal stem cell behavior. Science 2005, 309:1253-1256.
23. Flores I., Canela A., Vera E., Tejera A., Cotsarelis G., Blasco M.A. The longest telomeres: a general signature of adult stem cell compartments. Genes Dev. 2008, 22:654-667.
24. García-Cao I., García-Cao M., Martín-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.C., Blasco M.A., Serrano M. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 2002, 21:6225-6235.
25. González-Suárez E., Samper E., Flores J.M., Blasco M.A. Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 2000, 26:114-117.
26. Greider C.W., Blackburn E.H. Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985, 43:405-413.
27. Harley C.B., Futcher A.B., Greider C.W. Telomeres shorten during ageing of human fibroblasts. Nature 1990, 345:458-460.
28. Herrera E., Samper E., Martín-Caballero J., Flores J.M., Lee H.W., Blasco M.A. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 1999, 18:2950-2960.
29. Hinz B., Phan S.H., Thannickal V.J., Galli A., Bochaton-Piallat M.L., Gabbiani G. The myofibroblast: one function, multiple origins. Am. J. Pathol. 2007, 170:1807-1816.
30. King T.E., Pardo A., Selman M. Idiopathic pulmonary fibrosis. Lancet 2011, 378:1949-1961.
31. Lama V.N. Update in lung transplantation 2008. Am. J. Respir. Crit. Care Med. 2009, 179:759-764.
32. Lee H.W., Blasco M.A., Gottlieb G.J., Horner J.W., Greider C.W., DePinho R.A. Essential role of mouse telomerase in highly proliferative organs. Nature 1998, 392:569-574.
33. Leri A., Franco S., Zacheo A., Barlucchi L., Chimenti S., Limana F., Nadal-Ginard B., Kajstura J., Anversa P., Blasco M.A. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J. 2003, 22:131-139.
34. Liu Y., Snow B.E., Hande M.P., Yeung D., Erdmann N.J., Wakeham A., Itie A., Siderovski D.P., Lansdorp P.M., Robinson M.O., Harrington L. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr. Biol. 2000, 10:1459-1462.
35. Liu T., Chung M.J., Ullenbruch M., Yu H., Jin H., Hu B., Choi Y.Y., Ishikawa F., Phan S.H. Telomerase activity is required for bleomycin-induced pulmonary fibrosis in mice. J. Clin. Invest. 2007, 117:3800-3809.
36. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217.
37. Martínez P., Thanasoula M., Muñoz P., Liao C., Tejera A., McNees C., Flores J.M., Fernández-Capetillo O., Tarsounas M., Blasco M.A. Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice. Genes Dev. 2009, 23:2060-2075.
38. Martinez F.J., de Andrade J.A., Anstrom K.J., King T.E., Raghu G. Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N. Engl. J. Med. 2014, 370:2093-2101. Idiopathic Pulmonary Fibrosis Clinical Research Network.
39. Mouratis M.A., Aidinis V. Modeling pulmonary fibrosis with bleomycin. Curr. Opin. Pulm. Med. 2011, 17:355-361.
40. Rawlins E.L. Stem cells: Emergency back-up for lung repair. Nature 2015, 517:556-557.
41. Rock J.R., Barkauskas C.E., Cronce M.J., Xue Y., Harris J.R., Liang J., Noble P.W., Hogan B.L. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc. Natl. Acad. Sci. USA 2011, 108:E1475-E1483.
42. Ryu J.H., Moua T., Daniels C.E., Hartman T.E., Yi E.S., Utz J.P., Limper A.H. Idiopathic pulmonary fibrosis: evolving concepts. Mayo Clin. Proc. 2014, 89:1130-1142.
43. Schneider R.P., Garrobo I., Foronda M., Palacios J.A., Marión R.M., Flores I., Ortega S., Blasco M.A. TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells. Nat. Commun. 2013, 4:1946.
44. Selman M., King T.E., Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 2001, 134:136-151. American Thoracic Society, European Respiratory SocietyEuropean Respiratory Society, American College of Chest PhysiciansAmerican College of Chest Physicians.
45. Stanley S.E., Chen J.J., Podlevsky J.D., Alder J.K., Hansel N.N., Mathias R.A., Qi X., Rafaels N.M., Wise R.A., Silverman E.K., et al. Telomerase mutations in smokers with severe emphysema. J. Clin. Invest. 2015, 125:563-570.
46. Van der Velden J.L., Bertoncello I., McQualter J.L. LysoTracker is a marker of differentiated alveolar type II cells. Respir. Res. 2013, 14:123.
47. Vera E., Bernardes de Jesus B., Foronda M., Flores J.M., Blasco M.A. The rate of increase of short telomeres predicts longevity in mammals. Cell Rep. 2012, 2:732-737.
48. Zhang H.Y., Gharaee-Kermani M., Zhang K., Karmiol S., Phan S.H. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 1996, 148:527-537.